Literature DB >> 20052760

Microsatellite instability in the peripheral blood leukocytes of HNPCC patients.

Mary I Coolbaugh-Murphy1, Jing-Ping Xu, Louis S Ramagli, Brian C Ramagli, Barry W Brown, Patrick M Lynch, Stanley R Hamilton, Marsha L Frazier, Michael J Siciliano.   

Abstract

Most hereditary nonpolyposis colorectal cancer (HNPCC) patients inherit a defective allele of a mismatch repair (MMR) gene, usually MLH1 or MSH2, resulting in high levels of microsatellite instability (MSI-H) in the tumors. Presence of MSI in the normal tissues of mutation carriers has been controversial. Here we directly compare MSI in the peripheral blood leukocyte (PBL) DNA of seven HNPCC patients carrying different types of pathogenic MMR mutations in MLH1 and MSH2 genes with the PBL DNA of normal age-matched controls and of patients with sporadic colorectal cancer (SCRC). Small pool PCR (SP-PCR) was used studying three microsatellite loci for at least 100 alleles each in most samples. The average frequencies of mutant microsatellite fragments in each HNPCC patient (0.04-0.24) were significantly higher (p<0.01) relative to their age-matched normal controls with mutant frequencies (MF) from 0.00 to 0.06, or SCRC patients (MF from 0.01-0.03). The data support the conclusions that higher MF in the PBL DNA of HNPCC patients is real and reproducible, may vary in extent according to the type of germline MMR mutation and the age of the individual, and provide a possible genetic explanation for anticipation in HNPCC families. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20052760      PMCID: PMC3544178          DOI: 10.1002/humu.21190

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  40 in total

1.  Clinical uses of microsatellite instability testing in colorectal cancer: an ongoing challenge.

Authors:  C Richard Boland
Journal:  J Clin Oncol       Date:  2007-01-16       Impact factor: 44.544

2.  Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.

Authors:  M F Kane; M Loda; G M Gaida; J Lipman; R Mishra; H Goldman; J M Jessup; R Kolodner
Journal:  Cancer Res       Date:  1997-03-01       Impact factor: 12.701

3.  A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype.

Authors:  N C Nicolaides; S J Littman; P Modrich; K W Kinzler; B Vogelstein
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

4.  hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA.

Authors:  F Palombo; I Iaccarino; E Nakajima; M Ikejima; T Shimada; J Jiricny
Journal:  Curr Biol       Date:  1996-09-01       Impact factor: 10.834

5.  Mutation of a mutL homolog in hereditary colon cancer.

Authors:  N Papadopoulos; N C Nicolaides; Y F Wei; S M Ruben; K C Carter; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser; M D Adams
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

6.  hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.

Authors:  B Liu; R E Parsons; S R Hamilton; G M Petersen; H T Lynch; P Watson; S Markowitz; J K Willson; J Green; A de la Chapelle
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

7.  Semiautomated assessment of loss of heterozygosity and replication error in tumors.

Authors:  F Canzian; R Salovaara; A Hemminki; P Kristo; R B Chadwick; L A Aaltonen; A de la Chapelle
Journal:  Cancer Res       Date:  1996-07-15       Impact factor: 12.701

8.  Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.

Authors:  A Hemminki; P Peltomäki; J P Mecklin; H Järvinen; R Salovaara; M Nyström-Lahti; A de la Chapelle; L A Aaltonen
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

9.  Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.

Authors:  N C Nicolaides; N Papadopoulos; B Liu; Y F Wei; K C Carter; S M Ruben; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

10.  Mismatch repair deficiency in phenotypically normal human cells.

Authors:  R Parsons; G M Li; M Longley; P Modrich; B Liu; T Berk; S R Hamilton; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

View more
  15 in total

1.  Detection of DNA mismatch repair proteins in fresh human blood lymphocytes--towards a novel method for hereditary non-polyposis colorectal cancer (Lynch syndrome) screening.

Authors:  Samar Hassen; Bruce M Boman; Nawab Ali; Marcie Parker; Chandra Somerman; Zohra J Ali-Khan Catts; Akhtar A Ali; Jeremy Z Fields
Journal:  J Exp Clin Cancer Res       Date:  2011-10-21

Review 2.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 3.  Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC).

Authors:  Mei Hua Wong; Chuen Seng Tan; Soo Chin Lee; Yvonne Yong; Aik Seng Ooi; Joanne Ngeow; Min Han Tan
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

4.  The mRNA level of MLH1 in peripheral blood is a biomarker for the diagnosis of hereditary nonpolyposis colorectal cancer.

Authors:  Hong Yu; Hui Li; Yongan Cui; Wei Xiao; Guihong Dai; Junxing Huang; Chaofu Wang
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

5.  Anticipation in lynch syndrome: where we are where we go.

Authors:  Cristina Bozzao; Patrizia Lastella; Alessandro Stella
Journal:  Curr Genomics       Date:  2011-11       Impact factor: 2.236

6.  A Novel MLH1 Initiation Codon Mutation (c.3G>T) in a Large Chinese Lynch Syndrome Family with Different Onset Age and mRNA Expression Level.

Authors:  Yanni Zhang; Huishuang Chen; Zhiyu Peng; Santasree Banerjee; Wei Li; Zhaolong Zhao; Jianbin Sun; Jian Lv; Hui Huang; Ru Bai; Keke Lin; Zhongxin Li
Journal:  Biomed Res Int       Date:  2018-11-14       Impact factor: 3.411

7.  Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.

Authors:  Alexandra R Buckley; Trey Ideker; Hannah Carter; Olivier Harismendy; Nicholas J Schork
Journal:  Genome Med       Date:  2018-09-14       Impact factor: 11.117

8.  Mlh1 heterozygosity and promoter methylation associates with microsatellite instability in mouse sperm.

Authors:  Kul S Shrestha; Minna M Tuominen; Liisa Kauppi
Journal:  Mutagenesis       Date:  2021-07-07       Impact factor: 3.000

9.  Telomere length and genetic anticipation in Lynch syndrome.

Authors:  Nuria Seguí; Marta Pineda; Elisabet Guinó; Ester Borràs; Matilde Navarro; Fernando Bellido; Victor Moreno; Conxi Lázaro; Ignacio Blanco; Gabriel Capellá; Laura Valle
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

10.  Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing.

Authors:  Jonathan Kenyon; Gabrielle Nickel-Meester; Yulan Qing; Gabriela Santos-Guasch; Ellen Drake; Shuying Sun; Xiaodong Bai; David Wald; Eric Arts; Stanton L Gerson
Journal:  Int J Stem Cell Res Ther       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.